CA2262009A1 - Transport transdermique de molecules - Google Patents

Transport transdermique de molecules Download PDF

Info

Publication number
CA2262009A1
CA2262009A1 CA 2262009 CA2262009A CA2262009A1 CA 2262009 A1 CA2262009 A1 CA 2262009A1 CA 2262009 CA2262009 CA 2262009 CA 2262009 A CA2262009 A CA 2262009A CA 2262009 A1 CA2262009 A1 CA 2262009A1
Authority
CA
Canada
Prior art keywords
agents
molecules
lecithin
bromelain
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2262009
Other languages
English (en)
Inventor
Wilson T. Crandall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2262009A1 publication Critical patent/CA2262009A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

Cette invention se rapporte à des compositions et à des procédés qui servent au transport transdermique de molécules, notamment de macromolécules. Cette invention se rapporte également à des compositions et à des procédés servant au transport transdermique de molécules afin de traiter diverses pathologies chez des patients.
CA 2262009 1996-07-23 1997-07-23 Transport transdermique de molecules Abandoned CA2262009A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68523596A 1996-07-23 1996-07-23
US08/685,235 1996-07-23

Publications (1)

Publication Number Publication Date
CA2262009A1 true CA2262009A1 (fr) 1998-01-29

Family

ID=24751308

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2262009 Abandoned CA2262009A1 (fr) 1996-07-23 1997-07-23 Transport transdermique de molecules

Country Status (4)

Country Link
EP (1) EP0958355A1 (fr)
AU (1) AU4045097A (fr)
CA (1) CA2262009A1 (fr)
WO (1) WO1998003641A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210177975A1 (en) * 2011-12-05 2021-06-17 Incept, Llc Medical organogel processes and compositions

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998031369A1 (fr) * 1997-01-16 1998-07-23 Sekisui Chemical Co., Ltd. Preparations a usage externe a absorption percutanee
US6348450B1 (en) 1997-08-13 2002-02-19 The Uab Research Foundation Noninvasive genetic immunization, expression products therefrom and uses thereof
KR20080009171A (ko) * 1997-08-13 2008-01-24 더 유에이비 리서치 파운데이션 유전자 벡터의 국소 적용에 의한 백신접종
WO2001041732A1 (fr) * 1999-12-06 2001-06-14 Gore Stanley L Compositions et procedes d'administration intranasale d'agents actifs destines au cerveau
ES2535045T3 (es) 2003-04-10 2015-05-04 Vanderbilt Royalty Sub L.P. Usos y composiciones para administración de capsaicina
CA2598806A1 (fr) 2005-02-23 2006-08-31 Uab Research Foundation Vaccination amplifiee par alkyle-glycosides
NZ552816A (en) * 2007-01-24 2009-05-31 Bomac Research Ltd Formulation for transdermal administration of antihyperthyroid drug comprising a penetration enhancer selected from oleic acid, d-limonene, pyrrolidones, a C2-C8 alcohol, glycol ethers, triacetin and combinations thereof
WO2009101412A1 (fr) * 2008-02-13 2009-08-20 Cipla Limited Composition pharmaceutique topique
EP2601934A1 (fr) * 2009-01-22 2013-06-12 Ludwig-Maximilians-Universität München Gels phospholipidiques vésiculaires comportant des substances protéiques
US20130210840A1 (en) * 2010-06-11 2013-08-15 Imprimis Pharmaceuticals, Inc. Anti-Cellulite Composition and Method of Treating Cellulite
CA2925008A1 (fr) 2013-10-03 2015-04-09 Harrow Ip, Llc Compositions ophtalmiques a base d'epinephrine pour administration intraoculaire et leurs procedes de production
JP6891118B2 (ja) * 2014-12-23 2021-06-18 インテレクチュアル プロパティ アソシエイツ エルエルシーＩｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ａｓｓｏｃｉａｔｅｓ， ＬＬＣ 経皮投与のための方法及び製剤
AU2017209524A1 (en) * 2016-01-23 2018-08-16 Ampersand Biopharmaceuticals Inc. Enhanced transdermal delivery of active agents
EP3986464A4 (fr) * 2019-06-18 2023-07-05 Dyve Biosciences, Inc. Formulations de pénétration transdermique
US20240009320A1 (en) * 2020-11-25 2024-01-11 DePuy Synthes Products, Inc. Biocompatible organogel matrices for preparation of a drug delivery depot

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210177975A1 (en) * 2011-12-05 2021-06-17 Incept, Llc Medical organogel processes and compositions
US11890343B2 (en) * 2011-12-05 2024-02-06 Incept, Llc Medical organogel processes and compositions

Also Published As

Publication number Publication date
EP0958355A1 (fr) 1999-11-24
WO1998003641A1 (fr) 1998-01-29
AU4045097A (en) 1998-02-10

Similar Documents

Publication Publication Date Title
US6316428B1 (en) Topical moisturizing composition and method
JP4139860B2 (ja) 浸透増強および刺激減少システム
CA2262009A1 (fr) Transport transdermique de molecules
JP2953625B2 (ja) 薬剤／浸透促進組成物に関連する皮膚刺激を低下させる方法
AU2005203698B2 (en) Carrier
US7727537B2 (en) Stabilized compositions for topical administration and methods of making same
US7052715B2 (en) Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
US20060165823A1 (en) Topical delivery agents and methods for making and using therm
US20040018237A1 (en) Topical drug delivery using phosphatidylcholine
US7033998B2 (en) Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
KR20070072482A (ko) 치료적 응용을 위한 유기겔 제제형
DE69301920T2 (de) Arzneimittel zur transmucosalen verabreichung von peptiden
US20030157185A1 (en) Topical treatment of neuropathy
US7871647B1 (en) Topical treatment of neuropathy
KR20070034451A (ko) 저분자량 및 고분자량 화합물의 경피전달을 위한 혼합물
WO2006084353A1 (fr) Préparations stabilisées pour administration locale et méthodes d'élaboration desdites préparations
CN101199479A (zh) 一种药用亚微乳剂及其制备方法
AU624222B2 (en) Compositions containing thymopentin for topical treatment of skin disorders
US7291591B2 (en) Alcohol-free transdermal insulin composition
US20220273765A1 (en) Topical formulation
CN1263474C (zh) 局部止痒制剂及其制备方法
WO2005074892A1 (fr) Creme contenant des liposomes d'interferon
CN1470234A (zh) 皮肤用辣椒碱脂质体制剂
Potisuwan et al. The development of transfersomes containing Eulophia macrobulbon extract
Franzè et al. Lipid vesicles for (trans) dermal administration

Legal Events

Date Code Title Description
FZDE Dead